318 related articles for article (PubMed ID: 8687049)
1. [Anti-beta 2 glycoprotein 1 antibodies in idiopathic livedo reticularis].
Aubry F; Crickx B; Nicaise P; Labarre C; Viard JP; Belaïch S
Ann Dermatol Venereol; 1995; 122(10):667-70. PubMed ID: 8687049
[TBL] [Abstract][Full Text] [Related]
2. [Ischemic stroke in young patients and/or livedo: is it important to look for anti-beta 2-glycoprotein I antibodies?].
Granel F; de Maistre E; Challier B; Weber M; Weber M; Schmutz JL
Rev Med Interne; 1998 Oct; 19(10):709-12. PubMed ID: 9827442
[TBL] [Abstract][Full Text] [Related]
3. Sneddon's syndrome, anti-cardiolipin antibody and glomerular thrombosis.
Stevens JM; Hunt JE; Seymour AE; Krilis SA; Pugsley DJ
Clin Nephrol; 1994 Jan; 41(1):18-22. PubMed ID: 8137565
[TBL] [Abstract][Full Text] [Related]
4. [Anti-beta 2 glycoprotein I antibodies. Relationship with antiphospholipid antibodies and thrombosis].
Ordi Ros J; Falgà Tirado C; Monegal Ferran F; Selva O'Callaghan A; Pérez Pemán P; Cucurull E; Vilardell Tarres M
Med Clin (Barc); 1995 Feb; 104(7):245-8. PubMed ID: 7731286
[TBL] [Abstract][Full Text] [Related]
5. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
6. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
[TBL] [Abstract][Full Text] [Related]
7. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
8. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
9. Sneddon's syndrome, anticardiolipin antibodies and anticardiolipin cofactor. A case report.
Sinisi L; Palma V; Di Girolamo C; Scarpa R; Faccenda F; Rubba P; Cirillo S; Mansi D
Acta Neurol (Napoli); 1992 Apr; 14(2):134-9. PubMed ID: 1414558
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
[TBL] [Abstract][Full Text] [Related]
11. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
Arnoux D; Boutière B; Sanmarco M
Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
13. Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome.
Gantcheva M; Tsankov N
J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):157-60. PubMed ID: 10343946
[TBL] [Abstract][Full Text] [Related]
14. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
15. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
17. Clinical syndromes associated with lupus anticoagulants.
Kampe CE
Semin Thromb Hemost; 1994; 20(1):16-26. PubMed ID: 8059230
[TBL] [Abstract][Full Text] [Related]
18. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B
Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of anti-beta 2-glycoprotein I antibodies.
Amengual O; Atsumi T; Khamashta MA; Hughes GR
Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():15-7. PubMed ID: 8952753
[TBL] [Abstract][Full Text] [Related]
20. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
Bećarevic M; Andrejević S; Bonaci-Nikolić B; Obradović I; Miljić P; Majkić-Singh N
Clin Lab; 2005; 51(5-6):279-83. PubMed ID: 15991801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
